SYRINGE S2 20ML 18GA 1-1/2IN BD CHINA
Report
- Report Number
- 3002682307-2019-00314
- Event Type
- Malfunction
- Date Received
- May 16, 2019
- Date of Event
- May 7, 2019
- Report Date
- July 16, 2019
- Manufacturer
- BECTON DICKINSON, S.A.
- Product Code
- FMF
- PMA / PMN Number
- N/A
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- NURSE
Narratives
H.6. INVESTIGATION: BD WAS PROVIDED WITH A PHOTO AND SAMPLES FOR CATALOG 301948 LOT 1811364 TO INVESTIGATE THE RECORD. THE ANALYSIS OF THE SAMPLE SHOWED SMALL BLACK PARTICLES IN THE BODY OF THE SYRINGE, OUTSIDE THE FLUID PATH. AS A RESULT, BD WAS ABLE TO VERIFY THE REPORTED ISSUE. BD HAS DETERMINED THAT THE FOREIGN MATTER OF THE NON-CONFORMANCE CONSISTS OF VERY SMALL PIECE OF DUST MIXED WITH THE SILICONE OF THE SYRINGE. THE SILICONE OIL IS USED TO LUBRICATE THE INNER PART OF THE BARREL AND FACILITATE THE MOVEMENT OF THE PLUNGER ROD. THE DUST IN THIS CASE CAME FROM THE HOPPER OF THE ASSEMBLY MACHINE. IN THAT CASE, BD CONSIDERS THAT BECAUSE OF A PUNCTUAL FAILURE IN THE CLEANING PROCEDURES BY THE OPERATOR, THE PRESENCE OF THIS PARTICULATES IN THE HOPPER WAS NOT CORRECTLY AVOIDED MANUFACTURING.
IT WAS REPORTED THAT THE SYRINGE S2 20ML 18GA 1-1/2IN BD CHINA EXPERIENCED MOLD PRESENCE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: BEFORE USE, IT WAS FOUND BLACK FOREIGN MATTER ON PLUNGER, LIKE MOLD.
A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
IT WAS REPORTED THAT THE SYRINGE S2 20ML 18GA 1-1/2IN BD (B)(4) EXPERIENCED MOLD PRESENCE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: BEFORE USE, IT WAS FOUND BLACK FOREIGN MATTER ON PLUNGER, LIKE MOLD.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 407891 | SYRINGE S2 20ML 18GA 1-1/2IN BD CHINA | SYRINGE | FMF | BECTON DICKINSON, S.A. | 1811364 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |